Bilateral insufficiency fractures of the femoral condyles after discontinuation of glucocorticoid therapy for ulcerative colitis: A case report

Glucocorticoid therapy is a well-established risk factor for osteoporosis and insufficiency fractures. However, insufficiency fractures developing after discontinuation of glucocorticoid therapy have been infrequently described. We present a case of bilateral insufficiency fractures of the femoral condyles detected approximately one year after discontinuation of glucocorticoid therapy in a patient with ulcerative colitis. A 53-year-old man presented with progressive bilateral knee pain without antecedent trauma. He had previously received glucocorticoid therapy for ulcerative colitis, including oral prednisolone and budesonide. The last course had been discontinued approximately one year before symptom onset. Physical examination revealed bilateral weight-bearing pain with mild swelling but without redness or restriction of motion. Laboratory findings showed no inflammatory response, and plain X-rays showed no abnormalities. Magnetic resonance imaging revealed bilateral bone marrow edema and fracture lines in the femoral condyles, consistent with bilateral insufficiency fractures. Dual-energy X-ray absorptiometry confirmed osteoporosis, with T-scores of −2.4 at the lumbar spine and −3.3 at the femoral neck, and trabecular bone score was 1.171, suggesting that the trabecular microarchitecture was markedly degraded. He was treated with temporary non-weight-bearing rehabilitation and daily administration of abaloparatide. Knee pain gradually improved, and follow-up magnetic resonance imaging demonstrated resolution of signal abnormalities. Bone mineral density showed modest improvement, although trabecular bone score remained in the degraded range. In patients with a history of glucocorticoid exposure, bone fragility persists even after discontinuation of glucocorticoid therapy, and ongoing evaluation and treatment for osteoporosis are necessary.

Authors

Institutions

Publication Details

Journal
Modern Rheumatology Case Reports
Published
2026-11-19
DOI
https://doi.org/10.1093/mrcr/rxag104
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Bilateral insufficiency fractures of the femoral condyles after discontinuation of glucocorticoid therapy for ulcerative colitis: A case report

陽 石黒, Ryoto Kura, Kazunari Takeuchi, Rie Kurose et al.
Modern Rheumatology Case Reports
Bone health and osteoporosis research
article

Bilateral insufficiency fractures of the femoral condyles after discontinuation of glucocorticoid therapy for ulcerative colitis: A case report

陽 石黒, Ryoto Kura, Kazunari Takeuchi, Rie Kurose, Takahiro Tsushima, Yuki Fujita, Yoshihide Nakamura
article en

Abstract

Glucocorticoid therapy is a well-established risk factor for osteoporosis and insufficiency fractures. However, insufficiency fractures developing after discontinuation of glucocorticoid therapy have been infrequently described. We present a case of bilateral insufficiency fractures of the femoral condyles detected approximately one year after discontinuation of glucocorticoid therapy in a patient with ulcerative colitis. A 53-year-old man presented with progressive bilateral knee pain without antecedent trauma. He had previously received glucocorticoid therapy for ulcerative colitis, including oral prednisolone and budesonide. The last course had been discontinued approximately one year before symptom onset. Physical examination revealed bilateral weight-bearing pain with mild swelling but without redness or restriction of motion. Laboratory findings showed no inflammatory response, and plain X-rays showed no abnormalities. Magnetic resonance imaging revealed bilateral bone marrow edema and fracture lines in the femoral condyles, consistent with bilateral insufficiency fractures. Dual-energy X-ray absorptiometry confirmed osteoporosis, with T-scores of −2.4 at the lumbar spine and −3.3 at the femoral neck, and trabecular bone score was 1.171, suggesting that the trabecular microarchitecture was markedly degraded. He was treated with temporary non-weight-bearing rehabilitation and daily administration of abaloparatide. Knee pain gradually improved, and follow-up magnetic resonance imaging demonstrated resolution of signal abnormalities. Bone mineral density showed modest improvement, although trabecular bone score remained in the degraded range. In patients with a history of glucocorticoid exposure, bone fragility persists even after discontinuation of glucocorticoid therapy, and ongoing evaluation and treatment for osteoporosis are necessary.

Modern Rheumatology Case Reports
Hirosaki University (JP)
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon